Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
RandomizEd phase II trial of Sunitinib four weeks on and two weeks off versus Two weeks on and One week off in metastatic clear-cell type REnal cell carcinoma: RESTORE trialJ L Lee, M K Kim, I Park, et al.
Molecular Endocrinology (Baltimore, Md.)|November 5, 1997
Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expressionH M Ryoo, H M Hoffmann, T Beumer, et al.
Journal of Dental Research|August 27, 2010
Polymorphisms in the Matrilin-1 gene and risk of mandibular prognathism in KoreansJ Y Jang, E K Park, H M Ryoo, et al.
Osteoarthritis and Cartilage|February 13, 2007
Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean populationJ Min Hong, T-H Kim, S-C Chae, et al.
Molecular and Cellular Biology|November 14, 2000
Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12K S Lee, H J Kim, Q L Li, et al.
Human Molecular Genetics|July 15, 2018
PIN1 is a new therapeutic target of craniosynostosisH R Shin, H S Bae, B S Kim, et al.
Journal of Cellular Biochemistry|March 24, 1999
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiationM H Lee, A Javed, H J Kim, et al.
British Journal of Cancer|January 24, 2008
Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology GroupJ G Kim, S K Sohn, Y S Chae, et al.
American Journal of Hematology|April 3, 2001
Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patientsC W Choi, B S Kim, J H Seo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2012
Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patientsS J Seong, M Lim, S K Sohn, et al.
Pageof 2